← Browse by Condition
Medical Condition
parkinson s disease pd
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for parkinson s disease pd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — parkinson s disease pd Clinical Trials
How many clinical trials are currently recruiting for parkinson s disease pd?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for parkinson s disease pd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for parkinson s disease pd?
parkinson s disease pd research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a parkinson s disease pd clinical trial?
Eligibility criteria for parkinson s disease pd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07568951
Recruiting
Enrollment
210 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07808346
Recruiting
Enrollment
18 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07316296 Phase 3
Recruiting
Enrollment
60 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
NCT07348705
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
University of Florida
NCT07705373
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
Boston University Charles Rive...
NCT07798700
Recruiting
Enrollment
1,000 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07790744
Recruiting
Enrollment
100 pts
Location
Denmark
Sponsor
Danish Research Centre for Mag...
Related Conditions
aging (1) freezing of gait (1) freezing of gait symptoms in parkinson disease (1) frontotemporal degeneration ftd (1) als amyotrophic lateral sclerosis (1) primary progressive aphasia ppa (1) familial frontotemporal lobar degeneration fftld (1) fronto temporal lobar dementia (1) dementia with lewy bodies dlb (1) cortical basal syndrome cbs (1) alzheimer s disease ad (1) progressive supranuclear palsy psp (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology